Nike's Latest Sell Call Is the One Worth Heeding—It Tells You the Stock Isn't Actually Cheap

Nike has taken a lot of hits over the past year, but the latest one is the first that should actually make a contrarian stop and think. On September 10, Morgan Stanley relaunched coverage of the stock with an Underweight rating and a $31 price target — the lowest on the Street, against a Visible Alpha consensus around $48. The shares closed below $37 that day, a roughly 12-year low, after losing more than 40% of their value so far this year.

In one sense, this is just one more unhappy headline for a stock that's had many. But it's worth separating the downgrades that are reactions to the price from the ones that are arguments about the business. Most sell calls on a falling stock are price-based noise: the target chases the shares down. Morgan Stanley's is thesis-based. Its analysts say the current valuation is "out of touch" with an increasingly fragmented sportswear landscape, and that the consensus forecast "embeds too much growth too soon." That is a claim about what the stock is actually worth, and it is the one kind of downgrade a contrarian has to take seriously — because it attacks the assumption that makes Nike look cheap.

Here's why the valuation argument lands. The contrarian's classic setup is a high-growth company whose forward multiple has compressed to roughly the market's while its revenue still grows at multiples of the market. That's the case where the bears carry the burden of proof. Nike is the mirror image: the multiple has come down to market-like territory, but the growth has not held up its end. The stock trades around 17 times forward earnings. On a company that grew revenue essentially zero in its most recent full year — flat on a reported basis, down 2% on a currency-neutral basis — that is a fair price for no growth, not a discount you're being handed.

The business numbers back that read. For fiscal 2026, the year ended May 31, revenue came in at $46.4 billion, and diluted earnings per share fell 3% to $2.10. The troubling detail isn't the headline, it's the mix: Nike's own direct-to-consumer channel and digital sales are shrinking while wholesale recovers, and the Converse brand collapsed 31%. And the largest single problem is China, where the athletic-apparel titan's sales have fallen roughly 30% since 2021 to their lowest level in eight years, squeezed by homegrown rivals and a shifting "China Chic" consumer mood. Management declined to offer a specific fiscal 2027 revenue or profit target — guidance that would have given the market something to anchor to.

Against that, consider the case for the beaten-down price. Nike's moat is battered but not dead: it still owns one of the strongest sports brands in the world, and management is two years into a turnaround under Elliott Hill, who rejoined in late 2024 blaming much of the damage on his predecessor. Hill insists the company is "not managing this company quarter-to-quarter" and that progress "will not be a straight line." The balance sheet gives the turnaround room — roughly net cash, with a $7.6 billion cash hoard. And the dividend, recently raised, now yields about 4.4%.

That yield deserves a closer look before anyone anchors on it. Part of the reason the yield looks fat is simply that the denominator — the stock price — has collapsed. Nike's dividend now consumes roughly three-quarters of trailing earnings, while free cash flow fell about a third over the past year. A lofty yield built on a halved share price and a strained payout ratio is not the same cushion as a growing business throwing off cash. It's a floor, not a springboard.

So the honest contrarian read here is not "the market is pricing doom the numbers don't support." The latest bear call is arguing exactly the opposite, and this time the evidence is on the bear's side: a market multiple with no growth is not automatically a bargain, and the burden of proof rests with Nike's management to show the inflection, not with the analysts to prove it won't come. Two years into the turnaround with no revenue growth and no specific guidance, they've had the better of the argument so far.

That isn't a verdict that Nike can't work out eventually. It means the cheap-looking price is really a waiting game on the business, and the smart posture is patience rather than catching a falling knife because the stock is down a lot and pays a big dividend. Morgan Stanley itself flagged the moments that could reset expectations — the October earnings report or November investor day. Those, not price action, are the dates that tell you whether the market is wrong about Nike. The market deserves the benefit of the doubt until management gives it a reason not to.